Preliminary results of two new targeted therapies, now in late-stage clinical trials, hold much promise for men with hormone-refractory, or castration-resistant, prostate cancer.
Mike Toner
Advertisement
Articles by Mike Toner
New developments in the treatment and management of prostate cancer.
New options for advanced prostate cancer mean prolonged remission.
Advertisement
Latest Updated Articles
- Promise for Prostate
Published: December 9th 2010 | Updated:
- New Options in Androgen Therapy
Published: December 20th 2010 | Updated:
- And What Else Is New
Published: December 20th 2010 | Updated:
Advertisement
Advertisement
